EligibleTrials

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Recruiting · NCT00005095 · Observational (researchers observe without assigning treatment) · Lead sponsor: Northwestern University

View the official record on ClinicalTrials.gov →
Breast cancer

Interventions studied

Ca-125Surgeryscreening questionnaire administration

What this trial is about

RATIONALE: To improve strategies for detection and prevention of early-stage disease. PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.

Who can take part

Age range
18 Years to 80 Years
Sex
Female
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Eligibility criteria (as published)

DISEASE CHARACTERISTICS: * Meets one of the following criteria: * Considered to be at increased risk for developing ovarian cancer, as defined by one of the following: * Has at least one first-degree relative (mother, sister, or daughter) with ovarian, primary peritoneal, or fallopian tube cancer * Has at least two first or second degree relatives diagnosed before age 50 with either ovarian, primary peritoneal, fallopian tube, and/or pancreatic cancer who have tested positive for hereditary cancer syndrome that includes an increased risk of gynecologic cancer (e.g., BRCA1/2 or Lynch Syndrome)or have increased risk as deemed by a certified genetic counselor * A personal or family history of a hereditary cancer syndrome that includes an increased risk of gynecologic cancer * Increased risk as deemed by a certified genetic counselor * Undergoing surgery for a gynecologic condition, including any of the following: * Diagnosis of a reproductive cancer * Benign gynecological condition (e.g., uterine leiomyomata, endometriosis, pelvic inflammatory disease, or follicular or corpus luteum ovarian cysts) * Highly suspicious adnexal mass * Risk-reducing prophylactic oophorectomy PATIENT CHARACTERISTICS: Age * Between the ages of 18 and 80

Where it is running

1 location listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.